483
Views
0
CrossRef citations to date
0
Altmetric
Research Papers

Hepatitis C data justice: the implications of data-driven approaches to the elimination of hepatitis C

ORCID Icon, , , , , , , & show all
Pages 803-813 | Received 06 Apr 2023, Accepted 20 Nov 2023, Published online: 01 Dec 2023

References

  • Anti-Discrimination Board of New South Wales. (2001). C-change: Report of the enquiry into hepatitis C related discrimination.
  • Australian Associated Press. (2022, November 20). Medibank hackers release data on sexually transmitted infections after ransom demands unmet. SBS News.
  • Australian Department of Health. (2018). Fifth national hepatitis C strategy 2018-2022. https://www1.health.gov.au/internet/main/publishing.nsf/Content/ohp-bbvs-1
  • Australian Government. (2018). Fifth national aboriginal and torres strait islander blood borne viruses and sexually transmissible infections strategy 2018-2022. Department of Health.
  • Bajis, S., Dore, G. J., Hajarizadeh, B., Cunningham, E. B., Maher, L., & Grebely, J. (2017). Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review. International Journal of Drug Policy, 47, 34–46. https://doi.org/10.1016/j.drugpo.2017.07.002
  • Benjamin, R. (2016). Informed refusal: Toward a justice-based bioethics. Science, Technology, & Human Values, 41(6), 967–990. https://doi.org/10.1177/0162243916656059
  • Biondi, M. J., & Feld, J. J. (2020). Hepatitis C models of care: Approaches to elimination. Canadian Liver Journal, 3(2), 165–176. https://doi.org/10.3138/canlivj.2019-0002
  • Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
  • Broady, T. R., Cama, E., Brener, L., Hopwood, M., de Wit, J., & Treloar, C. (2018). Responding to a national policy need: Development of a stigma indicator for bloodborne viruses and sexually transmissible infections. Australian and New Zealand Journal of Public Health, 42(6), 513–515. https://doi.org/10.1111/1753-6405.12809
  • Buchbinder, M., Juengst, E., Rennie, S., Blue, C., & Rosen, D. L. (2022). Advancing a data justice framework for public health surveillance. AJOB Empirical Bioethics, 13(3), 205–213. https://doi.org/10.1080/23294515.2022.2063997
  • Carney, T. (2019). Robo-debt illegality: The seven veils of failed guarantees of the rule of law? Alternative Law Journal, 44(1), 4–10. https://doi.org/10.1177/1037969x18815913
  • Dawson, L., & Latham, S. R. (2020). Molecular HIV surveillance and public health ethics: Old wine in new bottles. The American Journal of Bioethics, 20(10), 39–41. https://doi.org/10.1080/15265161.2020.1806393
  • Declich, S., & Carter, A. O. (1994). Public health surveillance: Historical origins, methods and evaluation. Bulletin of the World Health Organization, 72(2), 285.
  • Dencik, L., Hintz, A., Redden, J., & Treré, E. (2022). Data justice. SAGE Publications.
  • Dore, G. J. (2021). Editorial: Elimination of hepatitis C in Australia by 2030: A decade and counting. Australian Prescriber, 44(2), 36–37. https://doi.org/10.18773/austprescr.2021.003
  • Evans, M., Valgarðsson, V., Jennings, W., & Stoker, G. (2020). Political trust and democracy in times of Coronavirus: Is Australia still the lucky country? (Report No. 7). Democracy 2025.
  • Fraser, S., & Seear, K. (2011). Making disease, making citizens: The politics of hepatitis C. Routledge.
  • Goggin, G., Vromen, A., Weatherall, K., Martin, F., & Sunman, L. (2019). Data and digital rights: Recent Australian developments. Internet Policy Review, 8(1), 1–19. https://doi.org/10.14763/2019.1.1390
  • Hutchings, E., Loomes, M., Butow, P., & Boyle, F. M. (2021). A systematic literature review of attitudes towards secondary use and sharing of health administrative and clinical trial data: A focus on consent. Systematic Reviews, 10(1), 132. https://doi.org/10.1186/s13643-021-01663-z
  • Johnson, J., Lenton, E., Henderson, C., Morgan, H., Forrest, M., Murray, J., Kidd, P., & Seear, K. (2017). La Trobe University.
  • Kagan, D., Seear, K., Lenton, E., Farrugia, A., Valentine, K., Mulcahy, S., & Fraser, S. (2023). ‘I’m not hep C free’: Afterlives of hepatitis C in the era of cure. Medical Humanities. https://doi.org/10.1136/medhum-2023-012653
  • Katzman, C., Mateu-Gelabert, P., Kapadia, S. N., & Eckhardt, B. J. (2019). Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination. International Journal of Drug Policy, 72, 33–39. https://doi.org/10.1016/j.drugpo.2019.04.003
  • Lenton, E., Johnson, J., & Brown, G. (2021). Upscaling HIV and hepatitis C testing in primary healthcare settings: Stigma-sensitive practice. Australian Journal of Primary Health, 27(4), 255–258. https://doi.org/10.1071/PY20176
  • MacLachlan, J. H., Smith, C., Towell, V., & Cowie, B. C. (2020). Viral hepatitis mapping project: National report 2018–19. https://ashm.org.au/programs/Viral-Hepatitis-Mapping-Project/
  • Maher, L., & Dixon, T. C. (2017). Collateral damage and the criminalisation of drug use. The Lancet HIV, 4(8), e326–e327. https://doi.org/10.1016/S2352-3018(17)30071-1
  • Marsh, P., & Kelly, L. (2018). Dignity of risk in the community: A review of and reflections on the literature. Health, Risk & Society, 20(5–6), 297–311. https://doi.org/10.1080/13698575.2018.1519115
  • Martinello, M., Hajarizadeh, B., & Dore, G. J. (2018). Editorial: Observations on the launch of new drugs for hepatitis C. Australian Prescriber, 41(1), 4. https://doi.org/10.18773/austprescr.2018.005
  • Molldrem, S., & Smith, A. K. J. (2020). Reassessing the ethics of molecular HIV surveillance in the era of cluster detection and response: Toward HIV data justice. The American Journal of Bioethics, 20(10), 10–23. https://doi.org/10.1080/15265161.2020.1806373
  • Mulcahy, S., Seear, K., Fraser, S., Farrugia, A., Kagan, D., Lenton, E., & Valentine, K. (2023). Performing hepatitis C, problematising “cure”: The construction of hepatitis C (cure) in social security and migration law. Law and Literature, 1–26. https://doi.org/10.1080/1535685X.2023.2221950
  • Parsell, C., & Marston, G. (2016). Supportive housing: Justifiable paternalism? Housing Theory & Society, 33(2), 195–216. https://doi.org/10.1080/14036096.2015.1135188
  • Parvin, N., & Pollock, A. (2020). Unintended by design: On the political uses of “unintended consequences”. Engaging Science, Technology, and Society, 6, 320–327. https://doi.org/10.17351/ests2020.497
  • Poll, R. (2013). Hepatitis C: The case against routine partner notification. International Journal of STD & AIDS, 24(3), 165–168. https://doi.org/10.1177/0956462412472311
  • Ruckenstein, M., & Schüll, N. D. (2017). The datafication of health. Annual Review of Anthropology, 46(1), 261–278. https://doi.org/10.1146/annurev-anthro-102116-041244
  • Seear, K., Fraser, S., Farrugia, A., & Valentine, K. (2021). Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C. International Journal of Drug Policy, 94, 103042. https://doi.org/10.1016/j.drugpo.2020.103042
  • Seear, K., Fraser, S., Mulcahy, S., Kagan, D., Lenton, E., Farrugia, A., & Valentine, K. (2023). Echoes and antibodies: Legal veridiction and the emergence of the perpetual hepatitis C subject. Social and Legal Studies, 32(2), 216–236. https://doi.org/10.1177/09646639221115698
  • Seear, K., & Lenton, E. (2021). Becoming posthuman: Hepatitis C, the race to elimination and the politics of remaking the subject. Health Sociology Review, 30(3), 229–243. https://doi.org/10.1080/14461242.2021.1971102
  • Smith, A. K., Davis, M. D., MacGibbon, J., Broady, T. R., Ellard, J., Rule, J., Cook, T., Duck-Chong, E., Holt, M., & Newman, C. E. (2023). Engaging stigmatised communities in Australia with digital health systems: Towards data justice in public health. Sexuality Research and Social Policy, 20(3), 1–12. https://doi.org/10.1007/s13178-023-00791-6
  • Stoové, M., Wallace, J., Higgs, P., Pedrana, A., Goutzamanis, S., Latham, N., Scott, N., Treloar, C., Crawford, S., Doyle, J., & Hellard, M. (2020). Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cure. International Journal of Drug Policy, 75, 102596. https://doi.org/10.1016/j.drugpo.2019.11.004
  • Walker, S., Wallace, J., Latham, N., Saich, F., Pedrana, A., Hellard, M., & Stoové, M. (2020). Using hepatitis C notification data to increase access to hepatitis C treatment and cure in Australia: A formative study. https://www.burnet.edu.au/events/320_ec_australia_november_webinar_series_webinar_2